Commitment to Communities

16 August 2013

Pfizer South Africa donates computer equipment to Kliptown Youth Program

The Kliptown Youth Program (KYP) is unique as it is a programme run ‘for the youth, by the youth’. Situated in Kliptown, the oldest township in Soweto, a small group of inspired youths work tirelessly to provide educational support and after-school activities for the disadvantaged children of Kliptown.

May 2013

Pfizer South Africa hosts Advocacy Capacity Building training

The first Pfizer South Africa (SA) advocacy capacity building training session took place on the 15th and 16th April this year. The interactive training was facilitated by AZAO, a Paris-based consultancy group. The training was not only the culmination...

Pfizer South Africa continues with its support of NWU HART Clinic

September 2012

Pfizer South Africa recently surprised the HART Clinic at the North-West University (NWU) in Potchefstroom, North West, with an announcement of its additional support to contribute towards the maintenance of a recently sponsored Toyota Quantum minibus for the next three years.

The announcement was made at the official opening of the Hypertension in Africa Research Team (HART) Clinic to Prof. Awie Koetze, NWU Dean of the Faculty of Human Sciences, and HART director Prof. Alta Schutte, followed by the handover of the brand new 16-seater minibus by Pfizer SA in February this year. The new maintenance sponsorship will be effective from 2013.

Pfizer South Africa launches initiative to encourage colleague volunteerism

August 2012

The Pfizer Big Hearts initiative was launched with a Grocery Collection Drive for the Lambano Sanctuary Homes.
'Pfizer Big Hearts'
Inspiring the volunteer in each of us!

Pfizer South Africa has launched an initiative called the “Pfizer Big Hearts”, which is aimed at mobilising its colleagues into a volunteerism culture. The initiative is in-line with the LeadSA framework which is based on the principle that making a difference in our society lies with each and every citizen who lives in it.

“At Pfizer we lead by demonstrating our on-going commitment to the communities in which we operate.”
- Lebogang Taunyane, Global Philanthropy Director, Africa

David Simmons, Jack Watters and Lebogang Taunyane pictured in Rwanda - Pfizer Global - Rwanda Media Event

Pfizer’s global corporate responsibility activities are focused on investing the full range of our resources - people, skills, expertise and funding - to broaden access to medicines and strengthen healthcare delivery for underserved people around the world. Several of Pfizer’s corporate public health partnerships have had a positive impact on healthcare in South Africa and, in fact, we have both a local CSR focus, as well as a global CSR focus (co-ordinated through Pfizer Global’s Philanthropy Division).

The locally-focused CSR programme includes the following initiatives which receive our support:

SOS Children’s Villages


Pfizer South Africa’s Biopharmaceutical Division is a long-term supporter of SOS Children’s Villages, providing the means to integrate orphaned, abused and abandoned children into normal families. The company supports over 20 children in two houses - one in Ennerdale, Johannesburg, and another in Thornton, Cape Town.

Bigshoes Foundation

We continue to remain a friend of the Bigshoes Foundation. Bigshoes protects the rights of vulnerable children through holistic health, treatment and family interventions so that they can grow up to fill big shoes. The organisation is committed to improving the medical care of orphaned and vulnerable children (OVC) with special emphasis on those affected by HIV/AIDS.

In recent years, the company has also provided support through grants to the following organisations:
Hospice Association of the Witwatersrand, Ubuntu Education Fund, Ikhwezi Lokusa, Pimville HIV/AIDS
Call Group, Zimbanathi Project, Childline and SADAG (educational grant).

Investing in our Future


Pfizer South Africa’s Biopharmaceutical Division believes in investing in its future - and the future of the communities in which it operates - through education. Over the years, the company has supported many academic initiatives at university level, which express a passion for making a difference in the lives of students and communities. These include charitable contributions to:

  • University of Witwatersrand (Bio-Ethics Prize/Award, run through the Steve Biko Centre for Bio-Ethics, “Justice in Healthcare”);
  • University of KwaZulu-Natal (sponsorship of the KZN National Young Health Scientists Research Symposium);
  • Rhodes University (final year pharmacy students community-based project - sponsorship of minibus);
  • University of the Free State (medical students transport project);
  • University of the North-West (Hypertension in Africa Research Team - HART)

Pfizer on the move

At Pfizer South Africa’s Biopharmaceutical Division, we believe that ‘charity begins at home’ and have therefore made a commitment to all Pfizer colleagues that we will continue to promote the ‘healthy minds lead to healthy bodies’ campaign. This internally-focused programme ensures that colleagues are encouraged to actively participate in a sport of their choice and potentially involve other colleagues in such activities. One such example is our growing support for both soccer (we have a male & female team) and cycling. We have gone as far as re-naming both soccer teams by way of an internally-driven ‘soccer naming competition’ which took place in September 2011. The women's team is ‘Pfiting Fit’ and the men's team is aptly called the ‘Pfinishers’.

1. Hypertension & Dyslipidaemia Media Event - took place on 27 October 2011

Prof. Wouter Jukema, keynote speaker at the Hypertension & Dyslipidaemia Media Event
Prof. Wouter Jukema, keynote speaker at the Hypertension & Dyslipidaemia Media Event

Twelve media representatives of leading local publications attended the event, on 27 October 2011, when Pfizer South Africa’s Biopharmaceutical Division was honoured to host Sandhya Singh (Director: Chronic Diseases, Disabilities & Geriatrics - Department of Health (DoH)) and her Deputy Director, Bilkus Sayed. The company continues to build meaningful relations with key DoH stakeholders and events such as these offer great opportunities for all parties to strengthen ties.

2. World Pneumonia Day Media Event - took place on 08 November 2011

Prof. Green and Sr. Ida Pretorius pictured with Pfizer colleagues


Pfizer South Africa's Biopharmaceutical division hosted a highly successful World Pneumonia Day Media Event on 08 November 2011, at the Pfizer Head Office. The presentations were well received. Prof. Green and Sr. Ida Pretorius provided the journalists with sound information on prevention and the need to vaccinate children under the ages of five. There was certainly a good media turn-out with 11 journalists (mainly trade) attending the event.

3. Pfizer colleagues put their mettle to the pedal - took place on 20 November 2011

Team Pfizer’ at the Momentum 94.7 Cycle Challenge

Twenty determined Pfizer colleagues and supporters committed themselves to preparing for the 2011 Momentum 94.7 Cycle Challenge. During training, they embraced the ‘cycle with a purpose’ philosophy and each cyclist canvassed sponsors to raise funds for various causes. Colleagues supported their energetic counterparts by pledging R1 per kilometre (or more) to be shared between an animal shelter (Wetnose) and an organisation that takes care of destitute families in Johannesburg (The Last Hope Organisation). Over R2000 was pledged.

Colleagues pictured attending the World AIDS Day Event

4. World AIDS Day Event at Pfizer Head Office - took place on 01 December 2011

The Pfizer H/O World AIDS Day Event went off extremely well with over 70 colleagues attending the function. The three guest speakers - two from Pfizer and one from Alexander Forbes - gave highly informative presentations that were well received by those in attendance. The key message delivered was that each and every one of us needs to behave responsibly and know our status by getting tested regularly, as well as educating our families and friends about the truly good work that Pfizer is doing in this regard.

Our Pfizer Global Commitment - Philanthropic work

The philanthropic platform includes a wide range of public health partnerships such as:

The Diflucan® Partnership Programme


On 01 December 2011, the Diflucan® Partnership Programme (DPP) marked its 11th year of continued commitment to providing, free of charge, the anti-fungal drug Diflucan® (fluconazole) for treatment of two opportunistic infections commonly associated with HIV and AIDS, namely cryptococcal meningitis and oesophageal candidiasis, in order to improve the lives of people living with the illness. To date, the DPP in South Africa has donated over 40 million in medicines and has reached over 700 health facilities, nationally.

Globally, the DPP has provided $1.2-billion USD in medicine to more than 2,400 sites in 63 countries in Africa, Asia, the Caribbean and Latin America.

Global Health Fellows


The Global Health Fellows programme is a corporate volunteer programme that places Pfizer colleagues on short-term assignments with international development organisations designed to address global health issues and improve care for underserved populations. Since its inception in 2003, over 270 Pfizer Global Health Fellows from offices around the world have participated in the programme, working in more than 40 countries. Assignments are focused on strengthening healthcare systems and include efforts such as building health information systems, training health workers, improving service delivery, and enhancing management of medicines, vaccines and technology.


In South Africa, 28 Fellows have served with various organisations, including the American Cancer Society/AORTIC, Broad Reach Health Care, Chris Hani Baragwanath Hospital, Project HOPE, USAID, International AIDS Vaccine Initiative and Mothers 2 Mothers.

Infectious Diseases Institute


In 2004, Pfizer established the Infectious Diseases Institute (IDI) in Kampala, Uganda, and has invested $60-million USD to date. IDI has become a regional Centre of Excellence for prevention, treatment, training and research that strengthens regional capacity in HIV and AIDS, malaria and tuberculosis. IDI has since trained over 8,500 healthcare providers from 27 African countries and provided care and treatment to some 40,000 patients throughout Uganda, with outreach to another 500,000. In addition, the IDI has produced 162 scholarly articles and 165 abstracts through over 50 research programmes.

Local Partnerships and Grants which receive Global support

Demonstrating our on-going commitment to education

As a good corporate citizen, Pfizer South Africa’s Biopharmaceutical Division recognises its responsibility towards making a contribution to the social development of the country. Over the years, the company has provided support to various organisations with projects focused in the areas of education, HIV and AIDS, child abuse and orphaned and vulnerable children.

These include:
Soweto Hospice

The company has been supporting the Soweto Hospice since 2003 to help provide HIV and AIDS care and support for the terminally ill, as well as community education, and has contributed over R3 million to support Soweto Hospice activities, over the years.

Ubuntu Education Fund


Pfizer South Africa’s Biopharmaceutical Division is an active partner of the Ubuntu Education Fund in Port Elizabeth; an organisation aimed at transforming the lives of orphaned and vulnerable children by providing them and their families with an empowering environment, as well as access to services and opportunities. For the past four years, the company has contributed over R1 million to support Ubuntu activities, enabling the organisation to greatly impact the lives of people infected and affected by HIV and AIDS in Zwide Township.

Text Size AAA

Living our full potential in striving for a healthier Southern Africa

Leadership Excellence Award & Best Employer in the Pharmaceutical category
Copyright © 2012 Pfizer South Africa All rights reserved.
Terms of Use | Privacy Policy | Access to Information policy |
The information contained in this site is intended only for residents of South Africa.
Powered by POP®
Follow us on: Facebook Twitter Youtube Add us: